Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2014 16:00 ET | Source: Novartis Pharma AG

Novartis study shows Zykadia(TM) shrank tumors in the majority of patients with ALK+ NSCLC, regardless of prior ALK treatment

Ceritinib achieved overall response rate of 58.5%, with a median progression-free survival of 8.2 months[1] Similar findings were observed in patients who started the study with brain metastases,...
June 02, 2014 16:00 ET | Source: Kilo Goldmines Ltd.

Kilo Goldmines Announces Corporate Update

TORONTO, ONTARIO--(Marketwired - June 2, 2014) - Kilo Goldmines Ltd. ("Kilo" or the "Corporation") (TSX VENTURE:KGL)(FRANKFURT:02K), a gold exploration company whose principal assets are...
June 02, 2014 16:00 ET | Source: Xcerra Corporation

Xcerra Announces Webcast of Upcoming 5th Annual Needham & Company SemiCap Equipment Corporate Access Day

NORWOOD, Mass., June 2, 2014 (GLOBE NEWSWIRE) -- Xcerra Corporation (Nasdaq:XCRA), today announced that it will present at the 5th Annual Needham & Co. SemiCap Equipment Corporate Access Day on...
June 02, 2014 16:00 ET | Source: ICU Medical, Inc.

ICU Medical, Inc. to Present at the 35th Annual Goldman Sachs Conference

SAN CLEMENTE, Calif., June 2, 2014 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq:ICUI), a leader in innovative medical devices used in infusion therapy, oncology and critical care applications,...
June 02, 2014 16:00 ET | Source: Colliers International Group Inc.

FirstService Acquires Real Estate Brokerage Firm in New Zealand

TORONTO, June 2, 2014 (GLOBE NEWSWIRE) -- FirstService Corporation (Nasdaq:FSRV) (TSX:FSV) announced today that its subsidiary, Colliers International ("Colliers"), has acquired Auckland-based Shore...
June 02, 2014 16:00 ET | Source: Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Presents Phase 1 Clinical Data Supporting Four Novel Antibody Therapeutic Programs at the 2014 ASCO Annual Meeting

CHICAGO, June 2, 2014 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Phase 1 clinical data from studies of MM-151, MM-141, MM-111 and MM-121 was presented at...
June 02, 2014 16:00 ET | Source: Measurement Specialties, Inc.

Measurement Specialties Acquires Wema System AS

HAMPTON, Va., June 2, 2014 (GLOBE NEWSWIRE) -- Measurement Specialties, Inc. (Nasdaq:MEAS), (the "Company"), a global designer and manufacturer of sensors and sensor-based systems, announced today the...
June 02, 2014 15:58 ET | Source: The Options Industry Council

The Options Industry Council Announces Options Volume Falls in May

CHICAGO, Ill, June 2, 2014 (GLOBE NEWSWIRE) -- via PRWEB - The Options Industry Council (OIC) announced today that 315,630,235 total options contracts traded in May, which is 18.32 percent less than...
June 02, 2014 15:55 ET | Source: Shoal Point Energy Ltd.

Shoal Point Energy Releases Fourth Quarter and January 31, 2014 Year End Financial Statements and Management Discussion and Analysis

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 2, 2014) - Shoal Point Energy (the "Company") (CSE:SHP)(OTCQX:SHPNF) is pleased to announce that the Company's fourth quarter and January...
June 02, 2014 15:55 ET | Source: Kantar Health

1 in 4 Women are Non-Adherent with Oral Endocrine Therapy for Breast Cancer, According to Kantar Health Research

NEW YORK, N.Y., June 2, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Nearly one in four women with breast cancer are non-adherent with their oral endocrine therapies, according to new findings from Kantar...

1 ...233206 233207 233208 ...326066